Table 1.
Clinical characteristics
| Characteristics | Control (n = 50) n % | Patients with hepatitis C without HCC (n = 50) n % | Patients with HCV-related HCC (n = 50) n % | Test of sig. | p | |||
|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||
| Male | 28 | 56.0 | 32 | 64.0 | 39 | 78.0 | χ2 = 5.526 | 0.063 |
| Female | 22 | 44.0 | 18 | 36.0 | 11 | 22.0 | ||
| Age (years) | F = 2.038 | 0.134 | ||||||
| Mean ±SD. | 49.82 ±7.03 | 51.70 ±9.28 | 53.06 ±7.70 | |||||
| Jaundice | 3 | 6.0 | 15 | 30.0 | χ2= 9.756* | 0.002* | ||
| Ascites | 2 | 4.0 | 34 | 68.0 | χ2 = 44.444* | < 0.001* | ||
| Hematemesis and melena | 3 | 6.0 | 16 | 32.0 | χ2= 10.981* | 0.001* | ||
| Hepatic encephalopathy | 2 | 4.0 | 14 | 28.0 | χ2= 10.714* | 0.001* | ||
| A | 45 | 90.0 | 0 | 0 | ||||
| B | 5 | 10.0 | 36 | 72.0 | ||||
| Child-Pugh classification | C | 0 | 0 | 14 | 28.0 | χ2 = 82.439* < 0.001* | ||
| BCLC staging | A | 7 | 14.0 | |||||
| B | 19 | 38.0 | ||||||
| C | 10 | 20.0 | ||||||
| D | 14 | 28.0 | ||||||
Child-Pugh – classification of liver cirrhosis, BCLC– Barcelona Clinic Liver Cancer staging system, F – ANOVA test, p-value for comparing between the studied groups, *statistically significant at p ≤ 0.05